Literature DB >> 26513549

TransVar: a multilevel variant annotator for precision genomics.

Wanding Zhou1, Tenghui Chen1, Zechen Chong1, Mary A Rohrdanz1, James M Melott1, Chris Wakefield1, Jia Zeng2, John N Weinstein1,3, Funda Meric-Bernstam2,4,5, Gordon B Mills2,3, Ken Chen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26513549      PMCID: PMC4772859          DOI: 10.1038/nmeth.3622

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  6 in total

1.  A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3.

Authors:  Pablo Cingolani; Adrian Platts; Le Lily Wang; Melissa Coon; Tung Nguyen; Luan Wang; Susan J Land; Xiangyi Lu; Douglas M Ruden
Journal:  Fly (Austin)       Date:  2012 Apr-Jun       Impact factor: 2.160

2.  Oncotator: cancer variant annotation tool.

Authors:  Alex H Ramos; Lee Lichtenstein; Manaswi Gupta; Michael S Lawrence; Trevor J Pugh; Gordon Saksena; Matthew Meyerson; Gad Getz
Journal:  Hum Mutat       Date:  2015-03-16       Impact factor: 4.878

3.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

4.  Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor.

Authors:  William McLaren; Bethan Pritchard; Daniel Rios; Yuan Chen; Paul Flicek; Fiona Cunningham
Journal:  Bioinformatics       Date:  2010-06-18       Impact factor: 6.937

5.  PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse.

Authors:  Peter V Hornbeck; Jon M Kornhauser; Sasha Tkachev; Bin Zhang; Elzbieta Skrzypek; Beth Murray; Vaughan Latham; Michael Sullivan
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

6.  Acquired resistance L747S mutation in an epidermal growth factor receptor-tyrosine kinase inhibitor-naïve patient: A report of three cases.

Authors:  Fumihiro Yamaguchi; Kunihiko Fukuchi; Yohei Yamazaki; Hiromi Takayasu; Sakiko Tazawa; Hidetsugu Tateno; Eisuke Kato; Aya Wakabayashi; Mami Fujimori; Takuya Iwasaki; Makoto Hayashi; Yutaka Tsuchiya; Jun Yamashita; Norikazu Takeda; Fumio Kokubu
Journal:  Oncol Lett       Date:  2013-11-25       Impact factor: 2.967

  6 in total
  25 in total

1.  Nm-seq maps 2'-O-methylation sites in human mRNA with base precision.

Authors:  Qing Dai; Sharon Moshitch-Moshkovitz; Dali Han; Nitzan Kol; Ninette Amariglio; Gideon Rechavi; Dan Dominissini; Chuan He
Journal:  Nat Methods       Date:  2017-05-15       Impact factor: 28.547

2.  mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancers.

Authors:  Mulin Jun Li; Hongcheng Yao; Dandan Huang; Huanhuan Liu; Zipeng Liu; Hang Xu; Yiming Qin; Jeanette Prinz; Weiyi Xia; Panwen Wang; Bin Yan; Nhan L Tran; Jean-Pierre Kocher; Pak C Sham; Junwen Wang
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

Review 3.  Operationalization of Next-Generation Sequencing and Decision Support for Precision Oncology.

Authors:  Jia Zeng; Amber Johnson; Md Abu Shufean; Michael Kahle; Dong Yang; Scott E Woodman; Thuy Vu; Shhyam Moorthy; Vijaykumar Holla; Funda Meric-Bernstam
Journal:  JCO Clin Cancer Inform       Date:  2019-09

4.  Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).

Authors:  Hideki Tokunaga; Keita Iida; Atsushi Hozawa; Soichi Ogishima; Yoh Watanabe; Shogo Shigeta; Muneaki Shimada; Yumi Yamaguchi-Kabata; Shu Tadaka; Fumiki Katsuoka; Shin Ito; Kazuki Kumada; Yohei Hamanaka; Nobuo Fuse; Kengo Kinoshita; Masayuki Yamamoto; Nobuo Yaegashi; Jun Yasuda
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

5.  Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability.

Authors:  Kuan-Lin Huang; Yige Wu; Tina Primeau; Yi-Ting Wang; Yuqian Gao; Joshua F McMichael; Adam D Scott; Song Cao; Michael C Wendl; Kimberly J Johnson; Kelly Ruggles; Jason Held; Samuel H Payne; Sherri Davies; Arvin Dar; Christopher R Kinsinger; Mehdi Mesri; Henry Rodriguez; Matthew J Ellis; R Reid Townsend; Feng Chen; David Fenyö; Shunqiang Li; Tao Liu; Steven A Carr; Li Ding
Journal:  Mol Cell Proteomics       Date:  2019-06-13       Impact factor: 5.911

6.  Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations.

Authors:  Siddhartha Devarakonda; Sumithra Sankararaman; Brett H Herzog; Kathryn A Gold; Saiama N Waqar; Jeffrey P Ward; Victoria M Raymond; Richard B Lanman; Aadel A Chaudhuri; Taofeek K Owonikoko; Bob T Li; John T Poirier; Charles M Rudin; Ramaswamy Govindan; Daniel Morgensztern
Journal:  Clin Cancer Res       Date:  2019-07-12       Impact factor: 12.531

7.  Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer.

Authors:  Francisco Martínez-Jiménez; Ferran Muiños; Erika López-Arribillaga; Nuria Lopez-Bigas; Abel Gonzalez-Perez
Journal:  Nat Cancer       Date:  2019-12-02

Review 8.  Computational genomics tools for dissecting tumour-immune cell interactions.

Authors:  Hubert Hackl; Pornpimol Charoentong; Francesca Finotello; Zlatko Trajanoski
Journal:  Nat Rev Genet       Date:  2016-07-04       Impact factor: 53.242

9.  Using MARRVEL v1.2 for Bioinformatics Analysis of Human Genes and Variant Pathogenicity.

Authors:  Julia Wang; Dongxue Mao; Fatima Fazal; Seon-Young Kim; Shinya Yamamoto; Hugo Bellen; Zhandong Liu
Journal:  Curr Protoc Bioinformatics       Date:  2019-09

10.  Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes.

Authors:  Shayantan Banerjee; Karthik Raman; Balaraman Ravindran
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.